Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$3.4 - $4.24 $1,162 - $1,450
-342 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$3.76 - $5.14 $139,966 - $191,336
-37,225 Reduced 99.09%
342 $1,000
Q4 2019

Feb 05, 2020

SELL
$6.48 - $8.76 $21,384 - $28,908
-3,300 Reduced 8.07%
37,567 $253,000
Q4 2018

Feb 08, 2019

BUY
$7.65 - $12.83 $45,900 - $76,980
6,000 Added 17.21%
40,867 $334,000
Q1 2018

May 10, 2018

BUY
$6.6 - $13.91 $51,645 - $108,845
7,825 Added 28.94%
34,867 $356,000
Q4 2017

Feb 13, 2018

BUY
$5.89 - $7.21 $45,353 - $55,517
7,700 Added 39.81%
27,042 $175,000
Q2 2017

Aug 11, 2017

BUY
N/A
19,342
19,342 $102,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.